[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fg9dvjiVcF4MBPEUoicygXjZoscplsMBBNGWClAALRCU":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":60,"rows":67},"Goldman, Butterwick, Fitzpatrick and Groff",[4],40,false,11,4,919,9,25,[14,17,19,22,25,28,30,32],{"name":15,"count":16},"Wrinkle",5,{"name":18,"count":9},"Skin Laxity",{"name":20,"count":21},"Laxity; Skin",3,{"name":23,"count":24},"Leg Veins",2,{"name":26,"count":27},"Aging",1,{"name":29,"count":27},"Female Pattern Baldness",{"name":31,"count":27},"Improve Photoaging Signs",{"name":33,"count":27},"Exposure Laser",[35,40,45,50,55],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT06603857","Skin Care Regimen for Improving Photoaging Signs on the Face","2024-12-31","CE Ferulic",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT06638905","Efficacy and Safety of Skincare Serum and Cream for Anti-aging of Facial Skin","2025-03-05","Babor Ultimate ECM Repair Serum",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT07342413","Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias","2026-05-30","Right leg treated with Glycerin compounded with 1% Lidocaine and Epinephrine",{"nctId":51,"briefTitle":52,"date":53,"intervention":54},"NCT07462533","Assess Efficacy of a Nanodiamond Periprocedural Skin Care Regimen for Ablative Resurfacing","2026-07-30","Pavise Serum",{"nctId":56,"briefTitle":57,"date":58,"intervention":59},"NCT07558603","Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 Agonist","2026-08-30","On GLP1 plus HRT",[61,62,63,64,65,66],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[68,91,109,136,154,178,196,214,236,254,279,305,331,349,376,394,419,437,463,488,512,537],{"intervention":49,"totalTrials":27,"cells":69},{"EARLY_PHASE1":70,"PHASE1":73,"PHASE2":75,"PHASE3":77,"PHASE4":79,"NA":89},{"trials":71,"activeCount":72},[],0,{"trials":74,"activeCount":72},[],{"trials":76,"activeCount":72},[],{"trials":78,"activeCount":72},[],{"trials":80,"activeCount":27,"soonestReadout":48},[81],{"nctId":46,"briefTitle":47,"status":82,"phases":83,"primaryCompletion":48,"completion":53,"start":84,"enrollment":85,"conditions":86,"interventions":87},"NOT_YET_RECRUITING",[65],"2026-02-01",20,[23],[49,88],"Left leg treated with Glycerin compounded with 1% Lidocaine and Epinephrine",{"trials":90,"activeCount":72},[],{"intervention":88,"totalTrials":27,"cells":92},{"EARLY_PHASE1":93,"PHASE1":95,"PHASE2":97,"PHASE3":99,"PHASE4":101,"NA":107},{"trials":94,"activeCount":72},[],{"trials":96,"activeCount":72},[],{"trials":98,"activeCount":72},[],{"trials":100,"activeCount":72},[],{"trials":102,"activeCount":27,"soonestReadout":48},[103],{"nctId":46,"briefTitle":47,"status":82,"phases":104,"primaryCompletion":48,"completion":53,"start":84,"enrollment":85,"conditions":105,"interventions":106},[65],[23],[49,88],{"trials":108,"activeCount":72},[],{"intervention":110,"totalTrials":24,"cells":111},"Sham Comparator",{"EARLY_PHASE1":112,"PHASE1":114,"PHASE2":116,"PHASE3":124,"PHASE4":132,"NA":134},{"trials":113,"activeCount":72},[],{"trials":115,"activeCount":72},[],{"trials":117,"activeCount":27,"soonestReadout":53},[118],{"nctId":51,"briefTitle":52,"status":82,"phases":119,"primaryCompletion":53,"completion":58,"start":120,"enrollment":121,"conditions":122,"interventions":123},[63],"2026-03-20",8,[18],[54,110],{"trials":125,"activeCount":27,"soonestReadout":38},[126],{"nctId":36,"briefTitle":37,"status":82,"phases":127,"primaryCompletion":38,"completion":128,"start":129,"enrollment":6,"conditions":130,"interventions":131},[63,64],"2025-02-28","2024-09-27",[31],[39,110],{"trials":133,"activeCount":72},[],{"trials":135,"activeCount":72},[],{"intervention":39,"totalTrials":27,"cells":137},{"EARLY_PHASE1":138,"PHASE1":140,"PHASE2":142,"PHASE3":144,"PHASE4":150,"NA":152},{"trials":139,"activeCount":72},[],{"trials":141,"activeCount":72},[],{"trials":143,"activeCount":72},[],{"trials":145,"activeCount":27,"soonestReadout":38},[146],{"nctId":36,"briefTitle":37,"status":82,"phases":147,"primaryCompletion":38,"completion":128,"start":129,"enrollment":6,"conditions":148,"interventions":149},[63,64],[31],[39,110],{"trials":151,"activeCount":72},[],{"trials":153,"activeCount":72},[],{"intervention":44,"totalTrials":27,"cells":155},{"EARLY_PHASE1":156,"PHASE1":158,"PHASE2":160,"PHASE3":162,"PHASE4":174,"NA":176},{"trials":157,"activeCount":72},[],{"trials":159,"activeCount":72},[],{"trials":161,"activeCount":72},[],{"trials":163,"activeCount":27,"soonestReadout":43},[164],{"nctId":41,"briefTitle":42,"status":82,"phases":165,"primaryCompletion":43,"completion":166,"start":167,"enrollment":168,"conditions":169,"interventions":172},[63,64],"2025-05-05","2024-10-28",18,[170,171],"Facial Wrinkles","Skin Aging",[44,173],"Babor Cure Cream",{"trials":175,"activeCount":72},[],{"trials":177,"activeCount":72},[],{"intervention":173,"totalTrials":27,"cells":179},{"EARLY_PHASE1":180,"PHASE1":182,"PHASE2":184,"PHASE3":186,"PHASE4":192,"NA":194},{"trials":181,"activeCount":72},[],{"trials":183,"activeCount":72},[],{"trials":185,"activeCount":72},[],{"trials":187,"activeCount":27,"soonestReadout":43},[188],{"nctId":41,"briefTitle":42,"status":82,"phases":189,"primaryCompletion":43,"completion":166,"start":167,"enrollment":168,"conditions":190,"interventions":191},[63,64],[170,171],[44,173],{"trials":193,"activeCount":72},[],{"trials":195,"activeCount":72},[],{"intervention":54,"totalTrials":27,"cells":197},{"EARLY_PHASE1":198,"PHASE1":200,"PHASE2":202,"PHASE3":208,"PHASE4":210,"NA":212},{"trials":199,"activeCount":72},[],{"trials":201,"activeCount":72},[],{"trials":203,"activeCount":27,"soonestReadout":53},[204],{"nctId":51,"briefTitle":52,"status":82,"phases":205,"primaryCompletion":53,"completion":58,"start":120,"enrollment":121,"conditions":206,"interventions":207},[63],[18],[54,110],{"trials":209,"activeCount":72},[],{"trials":211,"activeCount":72},[],{"trials":213,"activeCount":72},[],{"intervention":59,"totalTrials":27,"cells":215},{"EARLY_PHASE1":216,"PHASE1":218,"PHASE2":220,"PHASE3":222,"PHASE4":224,"NA":226},{"trials":217,"activeCount":72},[],{"trials":219,"activeCount":72},[],{"trials":221,"activeCount":72},[],{"trials":223,"activeCount":72},[],{"trials":225,"activeCount":72},[],{"trials":227,"activeCount":27,"soonestReadout":58},[228],{"nctId":56,"briefTitle":57,"status":82,"phases":229,"primaryCompletion":58,"completion":230,"start":231,"enrollment":232,"conditions":233,"interventions":234},[66],"2026-11-30","2026-04-20",50,[20],[59,235],"On GLP1 Only",{"intervention":235,"totalTrials":27,"cells":237},{"EARLY_PHASE1":238,"PHASE1":240,"PHASE2":242,"PHASE3":244,"PHASE4":246,"NA":248},{"trials":239,"activeCount":72},[],{"trials":241,"activeCount":72},[],{"trials":243,"activeCount":72},[],{"trials":245,"activeCount":72},[],{"trials":247,"activeCount":72},[],{"trials":249,"activeCount":27,"soonestReadout":58},[250],{"nctId":56,"briefTitle":57,"status":82,"phases":251,"primaryCompletion":58,"completion":230,"start":231,"enrollment":232,"conditions":252,"interventions":253},[66],[20],[59,235],{"intervention":255,"totalTrials":27,"cells":256},"air cooling",{"EARLY_PHASE1":257,"PHASE1":259,"PHASE2":261,"PHASE3":263,"PHASE4":265,"NA":277},{"trials":258,"activeCount":72},[],{"trials":260,"activeCount":72},[],{"trials":262,"activeCount":72},[],{"trials":264,"activeCount":72},[],{"trials":266,"activeCount":72},[267],{"nctId":268,"briefTitle":269,"status":270,"phases":271,"primaryCompletion":272,"completion":273,"start":274,"enrollment":85,"conditions":275,"interventions":276},"NCT04690803","The Effect of Cooling on Sclerotherapy Efficacy","UNKNOWN",[65],"2022-01-01","2022-12-01","2020-01-06",[23],[255],{"trials":278,"activeCount":72},[],{"intervention":280,"totalTrials":27,"cells":281},"Inggenol Mebutate 0.015%",{"EARLY_PHASE1":282,"PHASE1":284,"PHASE2":286,"PHASE3":288,"PHASE4":290,"NA":303},{"trials":283,"activeCount":72},[],{"trials":285,"activeCount":72},[],{"trials":287,"activeCount":72},[],{"trials":289,"activeCount":72},[],{"trials":291,"activeCount":72},[292],{"nctId":293,"briefTitle":294,"status":295,"phases":296,"primaryCompletion":297,"completion":297,"start":298,"enrollment":299,"conditions":300,"interventions":302},"NCT02446223","Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w\u002FIngenol Mebutate 0.015%","COMPLETED",[65],"2016-09","2015-01",21,[301],"Actinic Keratosis",[280],{"trials":304,"activeCount":72},[],{"intervention":306,"totalTrials":27,"cells":307},"aminolevulinic acid hydrochloride gel, 10%",{"EARLY_PHASE1":308,"PHASE1":310,"PHASE2":312,"PHASE3":314,"PHASE4":316,"NA":329},{"trials":309,"activeCount":72},[],{"trials":311,"activeCount":72},[],{"trials":313,"activeCount":72},[],{"trials":315,"activeCount":72},[],{"trials":317,"activeCount":72},[318],{"nctId":319,"briefTitle":320,"status":270,"phases":321,"primaryCompletion":322,"completion":323,"start":324,"enrollment":85,"conditions":325,"interventions":327},"NCT05359419","Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities",[65],"2023-08-30","2023-12-30","2022-05-15",[326],"Skin Neoplasms",[306,328],"aminolevulinic acid HCl topical solution, 20%",{"trials":330,"activeCount":72},[],{"intervention":328,"totalTrials":27,"cells":332},{"EARLY_PHASE1":333,"PHASE1":335,"PHASE2":337,"PHASE3":339,"PHASE4":341,"NA":347},{"trials":334,"activeCount":72},[],{"trials":336,"activeCount":72},[],{"trials":338,"activeCount":72},[],{"trials":340,"activeCount":72},[],{"trials":342,"activeCount":72},[343],{"nctId":319,"briefTitle":320,"status":270,"phases":344,"primaryCompletion":322,"completion":323,"start":324,"enrollment":85,"conditions":345,"interventions":346},[65],[326],[306,328],{"trials":348,"activeCount":72},[],{"intervention":350,"totalTrials":27,"cells":351},"Injectable sodium deoxycholate",{"EARLY_PHASE1":352,"PHASE1":354,"PHASE2":356,"PHASE3":358,"PHASE4":360,"NA":374},{"trials":353,"activeCount":72},[],{"trials":355,"activeCount":72},[],{"trials":357,"activeCount":72},[],{"trials":359,"activeCount":72},[],{"trials":361,"activeCount":72},[362],{"nctId":363,"briefTitle":364,"status":295,"phases":365,"primaryCompletion":366,"completion":367,"start":368,"enrollment":369,"conditions":370,"interventions":372},"NCT03361176","Kybella With Triamcinolone",[65],"2018-10-12","2018-12-18","2018-03-26",30,[371],"Adiposity",[350,373],"Injectable sodium deoxycholate with Triamcinolone acetate",{"trials":375,"activeCount":72},[],{"intervention":373,"totalTrials":27,"cells":377},{"EARLY_PHASE1":378,"PHASE1":380,"PHASE2":382,"PHASE3":384,"PHASE4":386,"NA":392},{"trials":379,"activeCount":72},[],{"trials":381,"activeCount":72},[],{"trials":383,"activeCount":72},[],{"trials":385,"activeCount":72},[],{"trials":387,"activeCount":72},[388],{"nctId":363,"briefTitle":364,"status":295,"phases":389,"primaryCompletion":366,"completion":367,"start":368,"enrollment":369,"conditions":390,"interventions":391},[65],[371],[350,373],{"trials":393,"activeCount":72},[],{"intervention":395,"totalTrials":27,"cells":396},"Sodium Deoxycholate",{"EARLY_PHASE1":397,"PHASE1":399,"PHASE2":401,"PHASE3":403,"PHASE4":405,"NA":417},{"trials":398,"activeCount":72},[],{"trials":400,"activeCount":72},[],{"trials":402,"activeCount":72},[],{"trials":404,"activeCount":72},[],{"trials":406,"activeCount":72},[407],{"nctId":408,"briefTitle":409,"status":295,"phases":410,"primaryCompletion":411,"completion":411,"start":412,"enrollment":85,"conditions":413,"interventions":415},"NCT03241563","Subcutaneous Sodium Deoxycholate Injections With or Without Triamcinolone for Reduction of Submental Fat",[65],"2017-02","2016-04",[414],"Fat Reduction",[395,416],"Triamcinolone",{"trials":418,"activeCount":72},[],{"intervention":416,"totalTrials":27,"cells":420},{"EARLY_PHASE1":421,"PHASE1":423,"PHASE2":425,"PHASE3":427,"PHASE4":429,"NA":435},{"trials":422,"activeCount":72},[],{"trials":424,"activeCount":72},[],{"trials":426,"activeCount":72},[],{"trials":428,"activeCount":72},[],{"trials":430,"activeCount":72},[431],{"nctId":408,"briefTitle":409,"status":295,"phases":432,"primaryCompletion":411,"completion":411,"start":412,"enrollment":85,"conditions":433,"interventions":434},[65],[414],[395,416],{"trials":436,"activeCount":72},[],{"intervention":438,"totalTrials":27,"cells":439},"tretinoin 0.05% lotion",{"EARLY_PHASE1":440,"PHASE1":442,"PHASE2":444,"PHASE3":446,"PHASE4":448,"NA":461},{"trials":441,"activeCount":72},[],{"trials":443,"activeCount":72},[],{"trials":445,"activeCount":72},[],{"trials":447,"activeCount":72},[],{"trials":449,"activeCount":72},[450],{"nctId":451,"briefTitle":452,"status":270,"phases":453,"primaryCompletion":454,"completion":455,"start":456,"enrollment":6,"conditions":457,"interventions":460},"NCT04096742","Altreno for Chest Rejuvenation",[65],"2021-07-30","2021-12-31","2019-08-06",[458,459],"Photodamaged Skin","Photoaging",[438],{"trials":462,"activeCount":72},[],{"intervention":464,"totalTrials":27,"cells":465},"Barrier Renew",{"EARLY_PHASE1":466,"PHASE1":468,"PHASE2":470,"PHASE3":472,"PHASE4":484,"NA":486},{"trials":467,"activeCount":72},[],{"trials":469,"activeCount":72},[],{"trials":471,"activeCount":72},[],{"trials":473,"activeCount":72},[474],{"nctId":475,"briefTitle":476,"status":270,"phases":477,"primaryCompletion":478,"completion":479,"start":480,"enrollment":85,"conditions":481,"interventions":483},"NCT05961579","Evaluating the Efficacy and Safety of Cleanser, Serum, and Sunscreen Products for Facial Redness.",[64],"2023-11-01","2023-11-30","2023-08-11",[482],"Redness",[464],{"trials":485,"activeCount":72},[],{"trials":487,"activeCount":72},[],{"intervention":489,"totalTrials":27,"cells":490},"enhanced DefenAge 8-in-1 BioSerum",{"EARLY_PHASE1":491,"PHASE1":493,"PHASE2":495,"PHASE3":497,"PHASE4":508,"NA":510},{"trials":492,"activeCount":72},[],{"trials":494,"activeCount":72},[],{"trials":496,"activeCount":72},[],{"trials":498,"activeCount":72},[499],{"nctId":500,"briefTitle":501,"status":270,"phases":502,"primaryCompletion":503,"completion":273,"start":504,"enrollment":85,"conditions":505,"interventions":507},"NCT05082766","Improvement in the Appearance of Periorbital Wrinkles",[64],"2022-10-11","2021-10-11",[506],"Periorbital Wrinkles",[489],{"trials":509,"activeCount":72},[],{"trials":511,"activeCount":72},[],{"intervention":513,"totalTrials":27,"cells":514},"Sodium Tetradecyl Sulfate",{"EARLY_PHASE1":515,"PHASE1":517,"PHASE2":519,"PHASE3":531,"PHASE4":533,"NA":535},{"trials":516,"activeCount":72},[],{"trials":518,"activeCount":72},[],{"trials":520,"activeCount":72},[521],{"nctId":522,"briefTitle":523,"status":270,"phases":524,"primaryCompletion":525,"completion":525,"start":526,"enrollment":527,"conditions":528,"interventions":530},"NCT05597995","Treatment of Epidermoid Cysts",[63],"2023-05-30","2022-11-01",10,[529],"Epidermoid Cyst",[513],{"trials":532,"activeCount":72},[],{"trials":534,"activeCount":72},[],{"trials":536,"activeCount":72},[],{"intervention":538,"totalTrials":27,"cells":539},"Antihistamine Cetirizine Hydrochloride",{"EARLY_PHASE1":540,"PHASE1":542,"PHASE2":544,"PHASE3":546,"PHASE4":548,"NA":550},{"trials":541,"activeCount":72},[],{"trials":543,"activeCount":72},[],{"trials":545,"activeCount":72},[],{"trials":547,"activeCount":72},[],{"trials":549,"activeCount":72},[],{"trials":551,"activeCount":72},[552],{"nctId":553,"briefTitle":554,"status":295,"phases":555,"primaryCompletion":556,"completion":557,"start":558,"enrollment":85,"conditions":559,"interventions":561},"NCT02451579","A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy",[66],"2016-12","2017-01","2015-02",[560],"Actinic Keratoses",[538]]